🇺🇸 FDA
Patent

US 12312357

PRMT5 inhibiting compounds and uses thereof

granted A61KA61K31/4985A61K31/506

Quick answer

US patent 12312357 (PRMT5 inhibiting compounds and uses thereof) held by ANTENGENE DISCOVERY LIMITED expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ANTENGENE DISCOVERY LIMITED
Grant date
Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/4985, A61K31/506, A61P, A61P35/00